Sizzling Stock Picks

[ManicTrader]

$CANB GlobeNewswire•June 13, 2018 Hicksville, New York, June 13, 2018 (GLOBE NEWSWIRE) -- Canbiola is proud to announce a Distribution and Licensing Agreement with Hudilab Inc., dba Endless Relief of Colorado. This new agreement will add to our continuing effort to grow the company’s revenue and product and service offerings. Endless Relief has developed and owns the Mobius Therapy Cannabidiol-Infused product line that delivers a specialized CBD formulation as transdermal medication delivered on its own or in conjunction with Transcutaneous Electrical Nerve Stimulation Therapy (TENS). The agreement calls for Canbiola to manufacture and to jointly market Endless Relief’s Mobius Therapy products.